Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Clinical trial NCT03838926 · RECRUITING
Trial details
- NCT number
- NCT03838926
- Sponsor
- Vanda Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2027-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.